Trinity Biotech (TRIB) Treasury Shares (2011 - 2025)

Trinity Biotech (TRIB) has reported Treasury Shares for 15 consecutive years, with $24.9 million the latest figure, recorded in Q4 2025.

• Quarterly Treasury Shares changed 0.0% year-over-year to $24.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $24.9 million, changed 0.0% from the prior year.
• Treasury Shares improved to $24.9 million in Q4 2025 per TRIB's latest filing, from -$24.9 million in the prior quarter.
• Over the last five years, Treasury Shares for TRIB reached as high as -$24.2 million in Q4 2019 and fell as low as -$28.7 million in Q4 2018.
• A 3-year average of -$26.8 million and a median of -$26.3 million in 2020 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2021 — Treasury Shares changed 0.0% — and 2023, when it surged 150.38%.
• Year by year, Treasury Shares stood at -$24.9 million in 2021, then changed by 0.0% to -$24.9 million in 2022, then jumped by 150.38% to $12.6 million in 2023, then surged by 98.49% to $24.9 million in 2024, then changed by 0.0% to $24.9 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $24.9 million, -$24.9 million, and $24.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.